Allworth Financial
NGEN icon

Allworth Financial’s NervGen Pharma NGEN Stock Holding History

Allworth Financial’s Portfolio NGEN Stock Details NGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.4K Hold
6,000
– – ﹤0.01% 3689
2026
Q2 		$12.4K Hold
6,000
– – ﹤0.01% 3570
2026
Q1 		$22.6K Buy
+6,000
New +$26K ﹤0.01% 2908

Other funds holding NGEN

Valley Forge Investment Consultants
Valley Forge Investment Consultants Audubon, Pennsylvania $405M AUM 13.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
PFG Investments
PFG Investments Woodbury, New York $2.64B AUM 26.11% 1-Year Est. Return
Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $159M AUM 62.27% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $67.2B AUM 18.61% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Allworth Financial's NGEN Position: Q3 2026 in Review

Allworth Financial held its NervGen Pharma (NGEN) position steady in Q3 2026 at 6,000 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3689.

Allworth Financial first reported a position in NGEN in Q1 2026 and has held it in 3 quarters since. The position peaked at $22.6K in Q1 2026. 49 funds tracked by Wall St. Rank hold NGEN as of Q3 2026.

  • Allworth Financial held 6,000 shares of NervGen Pharma worth $12.4K as of Q3 2026.
  • Allworth Financial left its NervGen Pharma share count unchanged in Q3 2026.
  • NervGen Pharma made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #3689 holding.
  • Allworth Financial first reported a position in NervGen Pharma in Q1 2026 and has held it in 3 quarters since.
  • Allworth Financial's NervGen Pharma position peaked at $22.6K in Q1 2026.
  • 49 funds tracked by Wall St. Rank held NervGen Pharma as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.